m

miniMarrow

1 employees

miniMarrow presents a new disruptive therapeutic approach for the in-situ production of blood components in leukemic patients.

Basic info

Industry

biotechnology research

Sectors

Bioengineering

Regeneration

Cell therapy

Bone marrow

Date founded

2020

Funding rounds raised

m

miniMarrow raised undisclosed on October 28, 2021

Investors: MassChallenge Switzerland

FAQ